Floriflam
فلوريفلام
Injectable solution combining Florfenicol 300 mg/ml (30%) and Flunixin meglumine 27.4 mg/ml (equivalent to 16.5 mg Flunixin base) for the treatment of bovine respiratory disease (BRD) caused by Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni associated with pyrexia in cattle.
Dosage Form
N/A
Product Type
Pharmaceutical
Manufacturer
Package
N/A
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Cattle | 2 ml / 15 kg b.wt. by single SC injection | subcutaneous | Single injection |
Withdrawal Periods
No withdrawal information available.
Indications
-
Curative treatment of respiratory infections caused by Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni associated with pyrexia in cattle.
علاج عدوى الجهاز التنفسي التي تسببها المانهايميا الحالة للدم، والباستوريلا مالتوسيدا، والهيستوفيلوس سومني المرتبطة بالحمى في الماشية.
Contraindications
No contraindications information available.
Precautions
No precautions information available.
Side Effects
No side effects information available.
Images
Documents
No documents available.
Active Ingredients
-
Florfenicol
300 mg/ml
-
Flunixin
17 mg/ml
Related Products
Related Products By Active Ingredient
Companies
-
ATCO Pharma for Pharmaceutical Industries
Manufacturer
Alternatives
No alternatives available.